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AbstrAct
Objective Time- dependent covariates are generally 
available as longitudinal data were collected periodically 
in the cohort study. To examine whether time- dependent 
triglyceride to high- density lipoprotein cholesterol (TG/
HDL- C) ratio could predict the future risk of type 2 diabetes 
mellitus (T2DM) and assess its potential impact on the risk 
of T2DM incidence.
Research design and methods This study enrolled 1460 
participants without T2DM aged 55 or above in 1992 in 
the Beijing Longitudinal Study of Aging during 25 years. 
The questionnaire data were collected in nine surveys 
from 1992 to 2017. Physical examination and blood 
laboratory tests including TG and HDL- C concentrations 
were measured in five surveys. Incident T2DM cases 
were confirmed via a self- reported history of T2DM or the 
fasting plasma glucose level.
Results 119 new cases of T2DM were identified. In the 
Cox regression analysis with time- dependent TG/HDL- C 
ratios and covariates, the adjusted hazard ratios (95% 
confidence interval) of T2DM incidence were 1.90 (1.12 
to 3.23), 2.75 (1.58 to 4.80) and 2.84 (1.69 to 4.77), 
respectively, for those with TG/HDL- C ratios (both TG 
and HDL- C were expressed in millimole per liter) in the 
ranges of 0.87–1.30, 1.31–1.74 and ≥1.75, compared 
with individuals with TG/HDL- C ratios <0.87. The similar 
results of subdistribution hazard ratios were obtained by 
performing the Fine- Gray model with time- dependent TG/
HDL- C ratios. This positive association and the statistically 
significant trend with increased risk of T2DM incidence 
in the three categories of elevated TG/HDL- C ratio was 
confirmed by multiple sensitivity analyses. Furthermore, 
the T2DM discriminatory power of TG/HDL- C ratio 
combining with other risk factors was moderately high.
Conclusions We found that time- dependent TG/HDL- C 
ratios were positively associated with the risk of T2DM 
risk. The elevated TG/HDL- C ratios increased the future 
risk of T2DM incidence. Lowering the TG/HDL- C ratio could 
assist in the prevention of diabetes for older adults.
InTROduCTIOn
Type 2 diabetes mellitus (T2DM) imposes 
a large economic burden on the global 
healthcare system.1 The prevalence of T2DM 
is steadily increasing everywhere, most mark-
edly in the world’s middle- income countries. 
China is experiencing the world’s largest 
diabetes epidemic. The prevalence of T2DM 
in Mainland China has risen from a low 0.67% 
in 1980 to an astounding 10.9% in 2013.2 The 
significance of this study
What is already known about this subject?
 ► A few studies have examined the association of tri-
glyceride to high- density lipoprotein cholesterol (TG/
HDL- C) ratio at baseline and the future risk of type 2 
diabetes mellitus (T2DM).
 ► Levels of TG and HDL- C commonly tend to fluctu-
ate over time. However, few studies have evaluated 
the association between the TG/HDL- C ratio and the 
risk of T2DM by accounting for time- dependent TG/
HDL- C ratios.
What are the new findings?
 ► Time- dependent TG/HDL- C ratios were positively 
associated with the future risk of T2DM incidence 
in the Beijing elderly population. Elevated TG/HDL- C 
ratios significantly increased the risk of T2DM inci-
dence. This positive association was confirmed by 
multiple sensitivity analyses.
 ► The association of TG/HDL- C ratios at baseline or 
the average ratios during the follow- up period with 
the future T2DM incidence was weaker or stronger, 
respectively, than the one between time- dependent 
TG/HDL- C ratios and T2DM incidence.
 ► The T2DM discriminatory powers of prediction mod-
els combining TG/HDL- C ratio and other risk factors 
were moderately high.
How might these results change the focus of 
research or clinical practice?
 ► Lowering TG/HDL- C ratio could assist to prevent 
T2DM in the general population, and monitoring lipid 
profile deserves more attention in clinical practice.
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International Diabetes Federation estimated the number 
of Chinese people aged 20–79 years with diabetes to be at 
114.4 million in 2017.3 Identifying modifiable risk factors 
and reducing the prevalence of these factors is essential 
for the prevention of T2DM.
Dyslipidemia such as elevated triglycerides (TGs) or 
decreased high- density lipoprotein cholesterol (HDL- C) 
is a common feature accompanying T2DM and pre- 
diabetic states.4–7 There are several prospective studies 
that have demonstrated elevated blood TG levels to 
increase the risk of diabetes,8–10 impaired glucose toler-
ance11 and impaired fasting glucose.12 Some studies 
have shown that HDL- C is inversely associated with the 
incidence of T2DM.13–15 Insulin resistance (IR) is a key 
risk factor for T2DM. The triglyceride to high- density 
lipoprotein cholesterol (TG/HDL- C) ratio has been 
reported to be a surrogate marker of IR.16–18 This might 
be a simple and reliable method to assess IR. However, 
only few prospective studies have evaluated the associa-
tion between the TG/HDL- C ratio at baseline and the 
incidence of T2DM.
To our knowledge, there have been only a 15- year 
prospective study in an urban community population 
and a rural cohort study that examined whether the 
higher TG/HDL- C ratio at baseline is associated with the 
increase risk of incident T2DM in Chinese people. It is 
worth noting that the majority of published studies19–22 
on this topic were based on a single measure of TG/
HDL- C ratio, failing to take into account the potential 
effect of change in the ratios over time. Many covariate 
data such as TG, HDL- C and blood pressure are collected 
regularly in longitudinal studies. They may fluctuate over 
time and are commonly addressed as time- dependent (or 
time- varying) covariates in statistics.23 24 Not accounting 
for time- dependent and cumulative average of the TG/
HDL- C ratio over time could bias the true association 
between the TG/HDL- C ratio and the risk of T2DM. 
Thus, prospective studies that evaluate the unbiased 
effect of the time- dependent TG/HDL- C ratio on the risk 
of T2DM in the presence of time- varying confounders 
are essential.
We took the opportunity of a well- designed prospec-
tive study of Beijing Longitudinal Study of Aging (BLSA) 
with 25 years of follow- up to investigate the associa-
tion between time- dependent TG/HDL- C ratios and 
the risk of T2DM incidence based on the longitudinal 
data. Furthermore, we also examined whether a single 
measure of TG/HDL- C ratio at baseline or average TG/
HDL- C ratio during the follow- up period was associated 
with the future risk of T2DM incidence.
ReseaRCH desIgn and meTHOds
study population
The BLSA is a community- based prospective cohort 
study specifically designed to investigate the risk factors 
for common non- communicable diseases of Chinese 
people aged 55 and older, which was started in 1992 and 
was implemented by the Capital Medical University.25 To 
select a representative sample whose geographic distri-
bution, economic status, age and education were similar 
to those of the Beijing population older than 55 years, 
a three- stage stratification- random clustering sampling 
method was conducted during cohort establishment. A 
full description of the design and implementation of this 
cohort study has been described previously.25 26 Briefly, 
3257 community residents who were from the Xuanwu 
District (urban), Daxing County (suburb, rural) and 
Huairou County (extended suburb, mountain), aged 
at least 55 years were invited to participate in 1992. A 
total of 2101 participants completed the questionnaire 
assessments and physical examination of the first survey 
from July 1992 to August 1992. These participants were 
followed up in 1994, 1997, 2000, 2004, 2007, 2009, 2012 
and 2017. In five surveys (1992, 2000, 2009, 2012 and 
2017), participants underwent physical examinations 
and laboratory tests. The data used in this study were 
from this cohort implemented during the period from 
1992 to 2017.
This study excluded 244 participants with diabetes 
(a self- reported history of T2DM or a fasting plasma 
glucose (FPG) concentration ≥7.0 mmol/L) at base-
line. We also excluded 395 individuals, who failed to 
complete the laboratory tests or had missing data for TG 
levels or HDL- C levels at baseline. We further excluded 
two participants who died from type 1 diabetes and had 
no history of T2DM. Therefore, 1460 participants with 
complete data were considered in the final analyses. 
This study was in accordance with the principles of the 
Declaration of Helsinki. All participants provided their 
written informed consent before taking part in this 
survey.
measurement and data collection
In nine surveys, a standard vis-à-vis questionnaire was 
used to collect the data on demographics (age, sex, resi-
dence and education level), behavior lifestyles (smoking 
status, alcohol consumption levels and physical activity) 
and the self- reported history of diseases. Heights and 
weights were measured, in light clothing, with the use of 
standardized stadiometers and scales, respectively. Blood 
pressure was measured on the right arm using a standard 
mercury sphygmomanometer or an electronic sphygmo-
manometer with the subjects resting for at least 5 min in 
a sitting position. The face- to- face interview and physical 
examination were conducted by trained senior medical 
students. All laboratory examinations, including total 
cholesterol (TC), low- density lipoprotein cholesterol 
(LDL- C), HDL- C, TGs, FPG, were performed at the labo-
ratory of Xuanwu Hospital, Capital Medical University 
(Beijing, China). All laboratory tests were measured by 
taking venous blood after at least 8 hours of fasting in the 
morning. Data were entered into a central database by an 
experienced researcher.
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assessments of Tg/HdL-C ratio
The TG/HDL- C ratio was calculated as TG (millimole per 
liter) divided by HDL- C (millimole per liter). Based on 
previously published cut- points of TG/HDL- C ratio,27–29 
the TG/HDL- C ratio was classified into four groups by 
the values of 0.87, 1.31, 1.75 which were in accordance 
with the values of 2.00, 3.00 and 4.00 when both TG and 
HDL- C were expressed in milligram per deciliter.
assessment of confounding covariates
In the present study, considering the degree of economic 
and educational level in Daxing County and Huairou 
County to be more or less equal, these two counties were 
combined into one group (ie, rural or non- urban sites). 
Body mass index (BMI) was calculated as the weight in 
kilograms divided by the height in meter square. Educa-
tional level was classified into the two groups: primary or 
lower level and secondary level or higher level. Alcohol 
use was defined as an average intake of alcohol of at least 
50 mL per day. Physical activity level was classified into 
the three groups of low, moderate and high with exercise 
time of <3, 3–10 and >10 hours per week, respectively.
assessments of incident T2dm
Incidence of T2DM was defined as a self- reported 
physician- diagnosed history of T2DM or a FPG concen-
tration ≥7.0 mmol/L (126 mg/dL).30 31 All participants 
were followed up for mortality from the baseline exam-
ination (July 1992) to the end of follow- up (December 
2017). Dates of death were obtained from the death 
certificates, hospital records, local police registry and the 
interview with family members. The follow- up time was 
accrued from the baseline to the date of T2DM, or the 
baseline to the date of death, loss of follow- up, whichever 
occurred first.
statistical analysis
Continuous variables were expressed as means±SD. 
Frequencies and percentages were used to express the 
categorical variables. Cox regression with time- dependent 
covariates was performed to estimate the association 
between TG/HDL- C ratio and the risk of T2DM inci-
dence. In the Cox regression, the last observation time 
of the lost follow- up participant or the death time was 
identified as the right- censored lifetime. To consider the 
potential impact of death as competing risk events rather 
than the right- censored, Fine- Gray’s proportional subdis-
tribution hazards model was used to assess the associa-
tion of TG/HDL- C with the risk of T2DM. Hazard ratio 
(HR) and subdistribution hazard ratio (SHR) with corre-
sponding 95% confidence interval (CI) were calculated 
from Cox regression and Fine- Gray model, respectively.
Four- step forward multivariable- adjusted models were 
built for the statistical analyses. Model 1 was adjusted for 
age, sex, district, educational level, cigarette consump-
tion, drinking status and physical activity level. Model 2 
was adjusted for variables in model 1, as well as for BMI, 
systolic blood pressure (SBP) and diastolic blood pressure 
(DBP). Model 3 was adjusted for variables in model 2 
plus TC and LDL- C. To examine whether the potential 
association between TG/HDL- C ratio and the risk of 
T2DM was due to the single measure of FPG at baseline, 
we further adjusted for FPG at baseline in model 4.
While for the analysis of time- dependent TG/HDL- C 
ratio, age, cigarette consumption, drinking status, phys-
ical activity, BMI, SBP, DBP, TC and LDL- C were updated 
during 1992–2012 as time- dependent confounders, and 
sex, educational level, residence and FPG at baseline 
were time- invariant variables. Longitudinal data of time- 
dependent TG levels and HDL- C levels collected during 
the follow- up time was used in the time- dependent Cox 
regression and time- dependent Fine- Gray model. Cox 
regression and Fine- Gray model with time- invariant TG/
HDL- C ratio and all confounding covariates measured 
at baseline or the average levels of continuous variables 
during the follow- up period were also implemented 
to explore its association with the risk of T2DM. The 
linear trend test across TG/HDL- C ratio categories was 
performed by assigning the median value to each cate-
gory and modeling this as a continuous variable in sepa-
rate regression models.
Multiple sensitivity analyses were performed to examine 
whether the potential association between TG/HDL- C 
ratio and the risk of T2DM was consistent. The restricted 
cubic spline was used to assess the dose–response relation-
ship between the average TG/HDL- C ratio and the risk 
of T2DM. Finally, risk prediction models including TG/
HDL- C and other risk factors were built for predicting 
the future T2DM incidence. The performance of these 
risk prediction models was evaluated by plotting the time- 
dependent Receiver Operating Characteristic (ROC) 
curves and calculating the areas under curves (AUCs).
For all analyses, a two- tailed p- value <0.05 was consid-
ered to be statistically significant. All statistical analyses 
were performed using R version 3.5.1 (R Foundation for 
Statistical Computing, Vienna, Austria) and SAS V.9.4 
(SAS Institute, Cary, North Carolina, USA).
ResuLTs
Among 1460 participants (733 men and 727 women) 
at baseline, the mean age of the study population 
was 68.82±8.50 years. Among these participants, the 
mean±SD, median, the 25th and 75th quartiles (IQR) of 
the follow- up duration were 9.68±6.76 years, 8.00 years, 
4.34 years and 13.52 years (9.18 years), respectively. 
During 14 133.21 person- years of follow- up, 119 new inci-
dent cases of T2DM were identified, 709 subjects died 
and 567 individuals lost to the follow- up. The cumulative 
newly onset incidence of T2DM was 8.42 per 1000 person- 
years overall. The flowchart of this study and the incident 
cases of T2DM in each survey is shown in figure 1. Table 1 
summarizes the characteristics of the subjects according 
to different surveys. During the follow- up, there were 
an increase in the proportion of physical activity and a 
reduction in smoking and alcohol intake.
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Figure 1 Flowchart of the study population and the incidence of T2DM during the 25- year follow- up time of nine surveys. 
(A) Flowchart of the participants included in the current study. (B) Flowchart of the participants developed to T2DM from 
1992 to 2017. FPG, fasting plasma glucose; HDL- C, high- density lipoprotein cholesterol; T2DM, type2 diabetes mellitus; TG, 
triglyceride.
The time- dependent TG/HDL- C ratios were posi-
tively and strongly associated with the future T2DM risk 
(table 2). After step- forward adjustment for confounding 
covariates, graded positive risk of T2DM incidence for 
those with step- elevated TG/HDL- C ratios was similar 
across four multivariable- adjusted models. In the anal-
yses of the final model adjusted simultaneously for all 
potential confounding factors, the HRs (95% CI) of 
newly onset T2DM for those with TG/HDL- C ratios when 
both TG and HDL- C were expressed in mmol/L (mg/
dL) in the ranges of 0.87–1.30 (2.00–2.99), 1.31–1.74 
(3.00–3.99) and ≥1.75 (4.00) were 1.90 (1.12 to 3.23), 
2.75 (1.58 to 4.80) and 2.84 (1.69 to 4.77), respectively, 
compared with individuals with TG/HDL- C ratios <0.87 
(2.00) (table 2). There were statistically significant trends 
with increased risks of T2DM incidence in the three cate-
gories of elevated TG/HDL- C ratios (p-values<0.001 for 
trend for all comparisons). In the competing risks regres-
sion analysis with the time- dependent covariates, the 
similar results of SHRs were obtained (table 2).
The association of TG/HDL- C ratios at baseline with 
the future T2DM incidence was weaker than the one 
for the association between time- dependent TG- HDL- C 
ratios and T2DM incidence. The HRs of T2DM inci-
dence for participants with baseline TG/HDL- C ratios 
in the ranges of 0.87–1.30, 1.31–1.74 and ≥1.75 at base-
line were 1.44 (0.84–2.48), 2.40 (1.39–4.17) and 2.53 
(1.51–4.24) compared with individuals with TG/HDL- C 
ratios <0.87, which were significantly less than those for 
time- dependent TG/HDL- C ratio groups (tables 2 and 
3). Furthermore, the group with TG/HDL- C ratios in the 
range of 0.87–1.30 was not significantly associated with 
the higher risk of T2DM (p- value=0.183) as compared 
with the group with TG/HDL- C ratio less than 0.87. 
The similar results of smaller SHRs of T2DM incidence 
for baseline TG/HDL- C ratio than time- dependent 
TG/HDL- C were observed. Whereas, the association of 
average TG/HDL- C ratios, based on the average level of 
continuous covariates such as age, BMI, SBP, DBP, TC 
and LDL- C during the follow- up period, with the T2DM 
risk was stronger than the one for the association between 
time- dependent TG- HDL- C ratios and T2DM incidence, 
in which the HRs of T2DM incidence for participants 
with average TG/HDL- C ratios in the ranges of 0.87–
1.30, 1.31–1.74 and ≥1.75 were 2.11 (1.22–3.65), 3.19 
(1.77–5.76) and 3.46 (2.03–5.88) compared with individ-
uals with TG/HDL- C ratios <0.87 in the Cox regression 
analysis (tables 2 and 3), respectively.
Moreover, the time- dependent TG/HDL- C ratios 
remained significantly associated with T2DM risk after 
restricting 1049 participants with the age less than 75 
years at baseline (figure 2A). In addition, we applied 
the Cox regression and Fine- Gray model only using the 
longitudinal data from 1992 to 2000, and we got the 
similar significantly positive association between TG/
HDL- C ratios and the risk of T2DM (online supplemen-
tary table S1). Equally important, we compared the asso-
ciation between TG/HDL- C ratios and T2DM incidence 
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Table 1 Characteristics of the study participants according to the survey time
Variables
1992
(N=1460)
2000
(N=664)
2009
(N=232)
2012
(N=122)
2017
(N=65)
Age (years) 68.82 (8.50) 73.62 (7.17) 79.49 (5.04) 82.10 (4.48) 85.51 (3.66)
Male, n (%) 733 (50.21) 317 (47.74) 99 (42.67) 51 (41.80) 30 (46.15)
Educational level, n (%)
  Secondary or higher 300 (20.55) 148 (22.29) 54 (23.28) 32 (26.23) 23 (35.38)
  Primary or lower 1160 (79.45) 516 (77.71) 178 (76.72) 90 (73.77) 42 (64.62)
Residence, n (%)
  Urban 828 (56.71) 338 (50.90) 94 (40.52) 52 (42.62) 33 (50.77)
  Rural 632 (43.29) 326 (49.10) 138 (59.48) 70 (57.38) 32 (49.23)
Smoke, n (%)
  0 1008 (69.04) 515 (77.56) 200 (86.21) 106 (86.89) 57 (87.69)
  1–5 105 (7.19) 46 (6.93) 9 (3.88) 3 (2.46) 2 (3.08)
  >5 347 (23.77) 103 (15.51) 23 (9.91) 13 (10.66) 6 (9.23)
Alcohol intake, n (%)
  Yes 186 (12.74) 68 (10.24) 16 (6.90) 8 (6.56) 6 (9.23)
  No 1274 (87.26) 596 (89.76) 216 (93.10) 114 (93.44) 59 (90.77)
Physical activity, hours/per week, n (%)
  <3 592 (40.55) 237 (35.69) 56 (24.14) 36 (29.51) 30 (46.15)
  3–10 604 (41.37) 256 (38.55) 96 (41.38) 51 (41.80) 20 (30.77)
  >10 264 (18.08) 171 (25.75) 80 (34.48) 35 (28.69) 15 (23.08)
BMI (kg/m2) 23.13 (3.86) 23.76 (3.86) 22.98 (3.94) 22.61 (4.38) 22.63 (4.33)
SBP (mm Hg) 141.2 (25.2) 142.3 (25.0) 143.7 (21.8) 142.3 (22.1) 141.4 (24.3)
DBP (mm Hg) 81.5 (12.5) 80.0 (12.0) 76.7 (11.4) 75.6 (11.1) 72.3 (12.4)
FPG (mmol/L) 5.17 (0.98) 5.15 (0.94) 5.09 (0.91) 5.05 (0.96) 4.94 (1.06)
TC (mmol/L) 4.34 (1.02) 5.14 (1.15) 5.46 (1.18) 5.27 (1.16) 5.26 (1.18)
TG (mmol/L) 1.47 (0.75) 1.52 (0.97) 1.54 (0.95) 1.45 (0.80) 1.46 (0.75)
LDL- C (mmol/L) 2.99 (0.98) 2.93 (0.86) 2.92 (0.82) 2.93 (0.87) 2.90 (0.89)
HDL- C (mmol/L) 1.51 (0.58) 1.65 (0.52) 1.46 (0.45) 1.49 (0.37) 1.47 (0.35)
TG/HDL- C 1.13 (0.87) 1.09 (1.03) 1.20 (0.96) 1.07 (0.71) 1.10 (0.75)
BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL- C, high- density lipoprotein cholesterol; LDL- C, low- 
density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.
using the data by 2000 (8- year duration), 2004 (12- year 
duration), 2012 (20- year duration) with the one by 2017 
(25- year duration), and consistent results were obtained 
(online supplementary figure S1). All sensitivity analyses 
presented the robust conclusion that high TG/HDL- C 
ratio was an independent risk factor of T2DM.
Significant positive association between average TG/
HDL- C ratio and T2DM risk was observed by performing 
a restricted cubic spline Cox regression (figure 2B). HRs 
and 95% CI were calculated for continuous TG/HDL- C 
ratios with respect to the reference value of 0.87 after 
simultaneous adjustment for all potential confounding 
factors. Based on the association between TG/HDL- C 
ratio and risk of T2DM, we found that there were signif-
icant dose–response relationships between the risk of 
T2DM incidence and the average TG/HDL- C ratios 
(p- value <0.001 for linearity of TG/HDL- C ratio in the 
Cox regression analysis). The HRs of incident T2DM 
were significantly higher in those with higher TG/HDL- C 
ratios compared with the reference level of 0.87.
We also analyzed other risk factors associated with the 
T2DM incidence. The multivariate Cox regression anal-
ysis showed that elevated FPG, high BMI and more ciga-
rette consumption were each positively associated with 
the risk of T2DM, while age was negatively associated 
with the risk of T2DM (online supplementary table S2). 
Notably, TG/HDL- C ratio was the strongest one among 
these associated risk factors.
Furthermore, a univariate Cox regression with TG/
HDL- C ratio and a multivariate prediction model 
including TG/HDL- C ratio, age, BMI, cigarette consump-
tion and FPG were built for predicting the future T2DM 
incidence. The discriminatory power of the multivariate 
model (full model) combining TG/HDL- C ratio with 
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Table 2 Adjusted HRs and SHRs (95% CI) for incidence of type 2 diabetes mellitus by TG/HDL- C ratio groups in the 
regression analyses with time- dependent TG/HDL- C ratio and covariates
TG/HDL- C ratio (mmol/L/mmol/L)
Ptrend<0.87 0.87–1.30 1.31–1.74 ≥1.75
Cox regression
  Model 1 1.00 2.15 (1.27 to 3.64) 3.45 (2.01 to 5.92) 3.58 (2.17 to 5.90) <0.001
  Model 2 1.00 1.98 (1.17 to 3.36) 2.88 (1.66 to 5.01) 2.92 (1.74 to 4.89) <0.001
  Model 3 1.00 1.95 (1.15 to 3.32) 2.83 (1.62 to 4.94) 2.90 (1.73 to 4.87) <0.001
  Model 4 1.00 1.90 (1.12 to 3.23) 2.75 (1.58 to 4.80) 2.84 (1.69 to 4.77) <0.001
Fine- Gray model
  Model 1 1.00 2.22 (1.32 to 3.75) 3.40 (1.98 to 5.83) 4.03 (2.44 to 6.64) <0.001
  Model 2 1.00 1.98 (1.17 to 3.36) 2.67 (1.53 to 4.64) 3.10 (1.85 to 5.20) <0.001
  Model 3 1.00 2.04 (1.20 to 3.47) 2.76 (1.58 to 4.82) 3.09 (1.84 to 5.19) <0.001
  Model 4 1.00 1.98 (1.16 to 3.37) 2.67 (1.53 to 4.68) 3.02 (1.80 to 5.08) <0.001
Model 1: Adjusted for age, sex, district, educational level, smoking consumption, drinking status and physical activity level.
Model 2: Included variables in model 1 and further adjusted for body mass index, systolic blood pressure and diastolic blood pressure.
Model 3: Adjusted for factors in model 2 plus total cholesterol and low- density lipoprotein cholesterol.
Model 4: Model 3 plus fasting plasma glucose.
HDL- C, high- density lipoprotein cholesterol; TG, triglyceride.
Table 3 Association of TG/HDL- C ratio with type 2 diabetes mellitus in the regression analyses with time- invariant ratio and 
covariates
TG/HDL- C ratio (mmol/L/mmol/L)
Ptrend<0.87 0.87–1.30 1.31–1.74 ≥1.75
Baseline TG/HDL- C
  No of subjects 688 359 197 216
  No of DM cases 28 27 28 36
  Incidence/1000
  person- years
4.34 7.61 14.18 16.62
  HR/SHR (95% CI)
Cox regression 1.00 1.44 (0.84 to 2.48) 2.40 (1.39 to 4.17) 2.53 (1.51 to 4.24) <0.001
Fine- Gray model 1.00 1.57 (0.91 to 2.69) 2.47 (1.42 to 4.29) 2.76 (1.64 to 4.63) <0.001
Average of TG/HDL- C
No of subjects 699 359 186 216
No of DM cases 24 30 24 41
Incidence/1000
person- years
3.61 8.57 13.18 18.89
  HR/SHR (95% CI)
Cox regression 1.00 2.11 (1.22 to 3.65) 3.19 (1.77 to 5.76) 3.46 (2.03 to 5.88) <0.001
Fine- Gray model 1.00 2.23 (1.28 to 3.86) 2.97 (1.65 to 5.37) 3.80 (2.23 to 6.49) <0.001
DM, diabetes mellitus; HDL- C, high- density lipoprotein cholesterol; SHR, subdistribution HR; TG, triglyceride.
other risk factors, where the risk score was calculated 
by 0.178*TG/HDL- C ratio - 0.040*age + 0.098*BMI + 
0.027*cigarette + 0.269*FPG, was moderately high with 
AUCs 0.713 (95% CI 0.620 to 0.805) and 0.733 (95% CI 
0.669 to 0.797), respectively, for 5- year and 10- year T2DM 
incidence. In addition, based on the results of Fine- 
Gray model analysis, a multivariate predication model 
accounting for the competing risk of death was set up 
with slightly higher AUCs 0.727 (95% CI 0.639 to 0.815) 
and 0.760 (95% CI 0.703 to 0.817), respectively, for 5- year 
and 10- year T2DM incidence (online supplementary 
figure S2).
dIsCussIOn
In this prospective community- based and 25- year longitu-
dinal follow- up study, we observed that time- dependent 
TG/HDL- C ratios were positively associated with the risk 
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Figure 2 Association between TG/HDL- C ratios and the risk of T2DM incidence. (A) Adjusted HRs and sub- HRs (F- G model) 
of T2DM incidence for different groups compared with the lowest group according to the time- dependent TG/HDL- C ratios 
in the regression analyses among the participants aged less than 75 years in 1992. (B). Adjusted dose–response relationship 
between the average TG/HDL- C ratios and the risk of T2DM using a restricted cubic spline curve with 95% CIs for HRs. F- G, 
Fine- Gray; HDL- C, high- density lipoprotein cholesterol; T2DM, type2 diabetes mellitus; TG, triglyceride.
of T2DM incidence. All sensitivity analyses showed that 
TG/HDL- C was an independent risk factor of T2DM. 
Multivariate prediction models combining TG/HDL- C 
ratio and other risk factors were built and they had 
moderately high discriminatory powers.
Some previous studies have demonstrated that high 
TG/HDL- C ratio was associated with an increased risk of 
T2DM.19–22 In a prospective cohort study including 5314 
participants of African- American, Hispanic, white and 
Chinese- American ethnicity, T2DM also developed to a 
significantly greater degree in subjects within the highest 
group of TG/HDL- C ratios with HR 1.82 (95% CI 1.38 to 
2.39) compared with individuals within the lowest group 
of TG/HDL- C ratios during a mean follow- up of 7.7 
years.20 In Chinese people, only two cohort studies have 
examined whether elevated TG/HDL- C ratios were asso-
ciated with the increased risk of T2DM incidence.19 22 One 
cohort study, which included only 687 urban- community 
adults of Chinese, conducted two surveys during a 
15- year follow- up and demonstrated that an increased 
TG/HDL- C ratios enhanced the risk of T2DM with an 
adjusted OR 1.341 (p- value=0.010).19 Another prospec-
tive study from the Rural Chinese Cohort Study with 
two surveys during 6- year follow- up and included 11 
946 adults of Chinese rural population also showed that 
people in the highest TG/HDL- C ratio group had the 
twice risk of developing T2DM incidence than those in 
the lowest ratio group with an HR of 2.11 (95% CI 1.55 
to 2.86).22 However, those two studies included either 
only urban or rural participants, which were not a good 
representative sample of Chinese people. Furthermore, 
since there were only two surveys in these two studies, the 
conclusions of the association were only based on a single 
measure. Few studies considered the effect of repeated- 
measurement of TG/HDL- C ratio and the possible role 
of time- varying confounders; thus, that might have biased 
the strength of the association between TG/HDL- C ratio 
and the incidence of T2DM. In our study that included 
both urban and rural adults of Chinese population, we 
have investigated the association of time- dependent 
TG/HDL- C ratios with the risk of T2DM incidence by 
adjusting for time- varying confounders meanwhile, 
which could reduce these deficiencies of the previous 
studies. Consistent with those findings, we discovered a 
higher T2DM risk with an increased TG/HDL- C ratio 
in multiple analyses. Moreover, the notion of the bias 
discrepancy supported by our observations that the HRs 
of T2DM risk for time- dependent TG/HDL- C ratios were 
significantly larger than those for baseline TG/HDL- C 
ratio in the current analysis. To the best of our knowl-
edge, this is the only multicommunity prospective study 
of Chinese population that used the TG/HDL- C ratio 
as a time- dependent variable to examine the potential 
impacts on T2DM risk.
Some previous reports provided some clues for under-
standing the mechanisms underlying this association of 
TG/HDL- C ratios and the risk of T2DM incidence. First, 
high plasma TG level can increase the IR of peripheral 
tissues. The intrinsic IR can attenuate the effect of insulin 
in suppressing TG lipolysis to glycerol and fatty acid, thus 
high level of TGs leads to the release of more free fatty 
acids.32 The latter can further exacerbate the problem 
of insulin sensitivity, a vicious cycle between elevated TG 
levels and IR,33 which may cause a further reduction in 
glucose uptake and utilization by the peripheral tissues.34 
Second, oxidation and inflammation can predict IR. 
As HDL- C has the ability of antioxidation and anti- 
inflammation, reduction in HDL- C may further lead to 
IR. Third, the combination of TG and HDL- C may have 
stronger predictability for IR and diabetes. Many studies 
have showed that the TG/HDL- C may be a proxy of 
IR to identify subjects at high risk of T2DM16 35 36 and 
suggested that the TG/HDL- C ratio may be a better 
surrogate marker of IR than single indicators such as 
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lipoprotein particle concentrations and size, glucose 
and insulin levels.28 35 This speculation is supported by 
the results from two large studies, which demonstrated 
that the ability of fibrates, drugs that raise the HDL- C 
levels and lower TG levels, seems to reduce IR and lower 
hazards for diabetes incidence.37 38
This study has several major strengths. It was a multi-
community and well- designed prospective study with 
follow- up period of 25 years. The data used in this study 
were robust and the conclusions were convincing based 
on a good representative sample of Chinese elderly 
people. To explore the approximated association in 
reality between TG/HDL- C ratio and the risk of T2DM 
incidence, repeated measurement of TG/HDL- C ratios 
were used to identify time- dependent variable, which 
correct regression dilution bias in analysis procedures 
and reflect more accurate evaluation of association 
between TG/HDL- C ratios and T2DM risk. Furthermore, 
this study benefited from detailed information of stan-
dardized procedures including the standard question-
naire, physical examination and laboratory test from 
each participant, allowing us to adjust for potential 
confounding factors. Lastly, extensive regression analyses 
with time- dependent, baseline and average TG/HDL- C 
ratios were employed to guarantee the robust results of 
the association between TG/HDL- C ratio and the risk of 
T2DM.
This study also has some limitations. First, T2DM was 
defined either as a self- reported history of T2DM and/
or an FPG ≥7.0 mmol/L, rather than based on a 2- hour 
oral glucose tolerance test or the measurement of hemo-
globin A1c. It is very likely that some participants, over a 
course of time, may have developed T2DM and were not 
diagnosed or another possibility can be that some partic-
ipants with type 1 diabetes were misdiagnosed as T2DM, 
when FPG level is met or exceeded 7.0 mmol/L. This 
missed diagnosis or misdiagnosis may bias the association 
between TG/HDL- C ratio and the T2DM risk. Second, 
the levels of TG and HDL- C could have been influenced 
by the fed- fasted state. Specific detailed dietary habits 
were not collected and cannot be completely controlled 
in the current study. Third, since our study only focused 
on Chinese elderly and the rate of lost follow- up during 
the surveys was relatively high, which may produce poten-
tial bias, further studies on the association between TG/
HDL- C ratios and the risk of T2DM with diverse popula-
tions and the low rate of lost follow- up would be needed 
for future generalizability.
In summary, our findings showed that time- dependent 
TG/HDL- C ratios were positively associated with the risk 
of T2DM. The elevated TG/HDL- C ratios increased the 
future risk of T2DM incidence. This emphasizes that 
lowering TG/HDL- C ratios might benefit not only from 
weakening “acute” effects on cardiovascular diseases but 
also from its “chronic” impact on the abnormal metabo-
lism of glucose; thus, attenuating the latter could assist 
to prevent diabetes in the general population. Given the 
rapidly increasing number of older adults, repeatedly 
measured lipid profile values are vital to predict the 
adverse health outcomes and deserve more attention in 
clinical practice.
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